Core Viewpoint - The article discusses the current state and future trends of the biomedical materials industry in China, highlighting the competitive landscape and the significance of various material types in the market [1][3]. Group 1: Industry Overview - The biomedical materials industry is categorized into five main types: metal materials, polymer materials, medical ceramics, composite materials, and medical-derived materials [1]. - In 2022, metal and polymer materials held a significant share in the biomedical materials market, while composite and bio-derived materials are expected to gain market share due to technological advancements and increased demand in the medical aesthetics sector [3]. Group 2: Innovation and Competitiveness - The Ministry of Industry and Information Technology and the National Medical Products Administration have initiated a collaborative innovation task for biomedical materials, with a notable number of polymer material companies leading in the selection of innovation tasks [6]. - Companies from Beijing and Shandong provinces have shown strong competitiveness, as they have the highest number of selected units in the first batch of innovation tasks [7]. Group 3: Market Development Trends - The development trends for various types of biomedical materials in China are as follows: - Metal materials are focusing on high-strength, low-modulus, bioactive modifications, and biodegradable alloys to enhance long-term compatibility of implants and reduce the need for secondary surgeries [13]. - Polymer materials are evolving towards high functionality, smart responsive designs, and biodegradable controls to meet the precise needs of medical applications [13]. - Medical ceramics are enhancing bioactivity, nanoscale modifications, and optimizing porous structures for complex tissue engineering applications [13]. - Composite materials are centered on low-cost mass production and high-performance multifunctional integration for advanced medical devices [13]. - Medical-derived materials are transitioning from passive repair to active induction through intelligent regeneration systems, integrating personalized medicine and tissue regeneration technologies [13].